# Compass, Inc.: financial statements, quarterly

COMP · NYSE · CIK 1563190 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/comp.md) · [Financials](/companies/comp/financials.md) · [Filings](/companies/comp/filings.md) · [Insiders](/companies/comp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/comp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,337](/filings/0001563190-24-000178.md) | [1,096 d](/filings/0001563190-26-000057.md) | [1,054](/filings/0001563190-25-000095.md) | [1,701](/filings/0001563190-25-000158.md) | [1,494](/filings/0001563190-25-000196.md) | [1,380 d](/filings/0001563190-26-000057.md) | [1,356](/filings/0001563190-26-000101.md) | [2,060](/filings/0001563190-26-000143.md) | [1,846](/filings/0001563190-25-000196.md) | [1,700 d](/filings/0001563190-26-000057.md) | [2,704](/filings/0001563190-26-000101.md) | [4,306](/filings/0001563190-26-000143.md) |
| Research and development | $m | [45.8](/filings/0001563190-24-000178.md) | [44.4 d](/filings/0001563190-26-000057.md) | [47.0](/filings/0001563190-25-000095.md) | [47.4](/filings/0001563190-25-000158.md) | [47.5](/filings/0001563190-25-000196.md) | [46.9 d](/filings/0001563190-26-000057.md) | [49.9](/filings/0001563190-25-000095.md) | [63.4](/filings/0001563190-25-000158.md) | [67.4](/filings/0001563190-25-000196.md) | [65.1 d](/filings/0001563190-26-000057.md) | not reported | not reported |
| Operating income | $m | [(38.9)](/filings/0001563190-24-000178.md) | [(83.0) d](/filings/0001563190-26-000057.md) | [(132)](/filings/0001563190-25-000095.md) | [21.3](/filings/0001563190-25-000158.md) | [(3.4)](/filings/0001563190-25-000196.md) | [(40.6) d](/filings/0001563190-26-000057.md) | [(54.0)](/filings/0001563190-26-000101.md) | [39.0](/filings/0001563190-26-000143.md) | [(7.2)](/filings/0001563190-25-000196.md) | [(41.9) d](/filings/0001563190-26-000057.md) | [(351)](/filings/0001563190-26-000101.md) | [124](/filings/0001563190-26-000143.md) |
| Interest expense | $m | [1.9](/filings/0001563190-23-000227.md) | [1.6 d](/filings/0001563190-24-000039.md) | [1.5](/filings/0001563190-24-000087.md) | [1.6](/filings/0001563190-25-000158.md) | [1.5](/filings/0001563190-25-000196.md) | [1.8 d](/filings/0001563190-26-000057.md) | [2.0](/filings/0001563190-26-000101.md) | [3.0](/filings/0001563190-26-000143.md) | [2.1](/filings/0001563190-25-000196.md) | [1.9 d](/filings/0001563190-26-000057.md) | [37.0](/filings/0001563190-26-000101.md) | [41.0](/filings/0001563190-26-000143.md) |
| Income tax | $m | [(0.5)](/filings/0001563190-24-000178.md) | [0.1 d](/filings/0001563190-26-000057.md) | [(0.3)](/filings/0001563190-25-000095.md) | [(0.1)](/filings/0001563190-25-000158.md) | [(0.3)](/filings/0001563190-25-000196.md) | [0.2 d](/filings/0001563190-26-000057.md) | [(3.0)](/filings/0001563190-26-000101.md) | [0.0](/filings/0001563190-26-000143.md) | [(0.2)](/filings/0001563190-25-000196.md) | [2.2 d](/filings/0001563190-26-000057.md) | [(401)](/filings/0001563190-26-000101.md) | [5.0](/filings/0001563190-26-000143.md) |
| Net income | $m | [(39.4)](/filings/0001563190-24-000178.md) | [(83.7) d](/filings/0001563190-26-000057.md) | [(133)](/filings/0001563190-25-000095.md) | [20.7](/filings/0001563190-25-000158.md) | [(1.7)](/filings/0001563190-25-000196.md) | [(40.5) d](/filings/0001563190-26-000057.md) | [(51.0)](/filings/0001563190-26-000101.md) | [39.0](/filings/0001563190-26-000143.md) | [(4.6)](/filings/0001563190-25-000196.md) | [(42.6) d](/filings/0001563190-26-000057.md) | [22.0](/filings/0001563190-26-000101.md) | [92.0](/filings/0001563190-26-000143.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001563190-24-000178.md) | not reported | [(0.27)](/filings/0001563190-25-000095.md) | [0.04](/filings/0001563190-25-000158.md) | [0.00](/filings/0001563190-25-000196.md) | not reported | [(0.09)](/filings/0001563190-26-000101.md) | [0.07](/filings/0001563190-26-000143.md) | [(0.01)](/filings/0001563190-25-000196.md) | not reported | [0.03](/filings/0001563190-26-000101.md) | [0.11](/filings/0001563190-26-000143.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001563190-24-000178.md) | not reported | [(0.27)](/filings/0001563190-25-000095.md) | [0.04](/filings/0001563190-25-000158.md) | [0.00](/filings/0001563190-25-000196.md) | not reported | [(0.09)](/filings/0001563190-26-000101.md) | [0.07](/filings/0001563190-26-000143.md) | [(0.01)](/filings/0001563190-25-000196.md) | not reported | [0.03](/filings/0001563190-26-000101.md) | [0.12](/filings/0001563190-26-000143.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [220](/filings/0001563190-23-000227.md) | [167](/filings/0001563190-25-000050.md) | [166](/filings/0001563190-24-000087.md) | [186](/filings/0001563190-24-000141.md) | [211](/filings/0001563190-24-000178.md) | [224](/filings/0001563190-26-000057.md) | [127](/filings/0001563190-25-000095.md) | [177](/filings/0001563190-25-000158.md) | [170](/filings/0001563190-25-000196.md) | [199](/filings/0001563190-26-000143.md) | [484](/filings/0001563190-26-000101.md) | [694](/filings/0001563190-26-000143.md) |
| Current assets | $m | [358](/filings/0001563190-23-000227.md) | [282](/filings/0001563190-25-000050.md) | [293](/filings/0001563190-24-000087.md) | [321](/filings/0001563190-24-000141.md) | [331](/filings/0001563190-24-000178.md) | [330](/filings/0001563190-26-000057.md) | [270](/filings/0001563190-25-000095.md) | [348](/filings/0001563190-25-000158.md) | [313](/filings/0001563190-25-000196.md) | [317](/filings/0001563190-26-000143.md) | [1,063](/filings/0001563190-26-000101.md) | [1,385](/filings/0001563190-26-000143.md) |
| Total assets | $m | [1,264](/filings/0001563190-23-000227.md) | [1,160](/filings/0001563190-25-000050.md) | [1,145](/filings/0001563190-24-000087.md) | [1,215](/filings/0001563190-24-000141.md) | [1,200](/filings/0001563190-24-000178.md) | [1,178](/filings/0001563190-26-000057.md) | [1,543](/filings/0001563190-25-000095.md) | [1,596](/filings/0001563190-25-000158.md) | [1,554](/filings/0001563190-25-000196.md) | [1,540](/filings/0001563190-26-000143.md) | [8,117](/filings/0001563190-26-000101.md) | [8,332](/filings/0001563190-26-000143.md) |
| Current liabilities | $m | [338](/filings/0001563190-23-000227.md) | [293](/filings/0001563190-25-000050.md) | [362](/filings/0001563190-24-000087.md) | [386](/filings/0001563190-24-000141.md) | [358](/filings/0001563190-24-000178.md) | [353](/filings/0001563190-26-000057.md) | [487](/filings/0001563190-25-000095.md) | [474](/filings/0001563190-25-000158.md) | [391](/filings/0001563190-25-000196.md) | [367](/filings/0001563190-26-000143.md) | [1,262](/filings/0001563190-26-000101.md) | [1,303](/filings/0001563190-26-000143.md) |
| Total liabilities | $m | [786](/filings/0001563190-23-000227.md) | [728](/filings/0001563190-25-000050.md) | [811](/filings/0001563190-24-000087.md) | [814](/filings/0001563190-24-000141.md) | [769](/filings/0001563190-24-000178.md) | [766](/filings/0001563190-26-000057.md) | [905](/filings/0001563190-25-000095.md) | [871](/filings/0001563190-25-000158.md) | [775](/filings/0001563190-25-000196.md) | [753](/filings/0001563190-26-000143.md) | [5,289](/filings/0001563190-26-000101.md) | [5,345](/filings/0001563190-26-000143.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001563190-26-000143.md) | [3,140](/filings/0001563190-26-000101.md) | [3,140](/filings/0001563190-26-000143.md) |
| Shareholders' equity | $m | [474](/filings/0001563190-23-000227.md) | [429](/filings/0001563190-25-000050.md) | [330](/filings/0001563190-24-000087.md) | [398](/filings/0001563190-24-000141.md) | [428](/filings/0001563190-24-000178.md) | [409](/filings/0001563190-26-000057.md) | [635](/filings/0001563190-25-000095.md) | [720](/filings/0001563190-25-000158.md) | [773](/filings/0001563190-25-000196.md) | [782](/filings/0001563190-26-000143.md) | [2,820](/filings/0001563190-26-000101.md) | [2,979](/filings/0001563190-26-000143.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [15.0 d](/filings/0001563190-24-000178.md) | [(38.7) d](/filings/0001563190-26-000057.md) | [8.6](/filings/0001563190-25-000095.md) | [45.0 d](/filings/0001563190-25-000158.md) | [37.4 d](/filings/0001563190-25-000196.md) | [30.5 d](/filings/0001563190-26-000057.md) | [23.0](/filings/0001563190-26-000101.md) | [73.0 d](/filings/0001563190-26-000143.md) | [75.4 d](/filings/0001563190-25-000196.md) | [45.3 d](/filings/0001563190-26-000057.md) | [(157)](/filings/0001563190-26-000101.md) | [191 d](/filings/0001563190-26-000143.md) |
| Capital expenditure | $m | [2.8 d](/filings/0001563190-24-000178.md) | [2.3 d](/filings/0001563190-26-000057.md) | [2.7](/filings/0001563190-25-000095.md) | [4.6 d](/filings/0001563190-25-000158.md) | [4.6 d](/filings/0001563190-25-000196.md) | [3.8 d](/filings/0001563190-26-000057.md) | [4.0](/filings/0001563190-26-000101.md) | [5.0 d](/filings/0001563190-26-000143.md) | [1.3 d](/filings/0001563190-25-000196.md) | [3.1 d](/filings/0001563190-26-000057.md) | [11.0](/filings/0001563190-26-000101.md) | [11.0 d](/filings/0001563190-26-000143.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [432](/filings/0001563190-23-000227.md) | [450](/filings/0001563190-24-000087.md) | [461](/filings/0001563190-24-000141.md) | [471](/filings/0001563190-24-000178.md) | [490](/filings/0001563190-25-000095.md) | [510](/filings/0001563190-25-000158.md) | [506](/filings/0001563190-25-000196.md) | [550](/filings/0001563190-26-000101.md) | [591](/filings/0001563190-26-000143.md) | [566](/filings/0001563190-25-000196.md) | [823](/filings/0001563190-26-000101.md) | [842](/filings/0001563190-26-000143.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 757,522,197 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001563190-26-000143.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.